 | • レポートコード：MRC2202A103 • 出版社/出版日：Mordor Intelligence / 2022年1月28日 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：バイオ |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Team User | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社は、世界の無菌サンプリング市場規模が、年平均10.24％成長すると予測しています。本調査レポートでは、無菌サンプリングの世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、サンプリング種類別（手動型無菌サンプリング、自動型無菌サンプリング）分析、用途別（上流プロセス、下流プロセス）分析、エンドユーザー別（バイオテクノロジー・製薬メーカー、委託研究・製造組織、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来傾向などを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の無菌サンプリング市場規模：サンプリング種類別（手動型無菌サンプリング、自動型無菌サンプリング） ・世界の無菌サンプリング市場規模：用途別（上流プロセス、下流プロセス） ・世界の無菌サンプリング市場規模：エンドユーザー別（バイオテクノロジー・製薬メーカー、委託研究・製造組織、その他） ・世界の無菌サンプリング市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Merck KGaA、Sartorius Stedim Biotech、Keofitt A/S、Saint Gobain、GEA Group、Qualitru Sampling Systems、Thermo Fisher Scientific、Gemu Group、Gore & Associates、Lonza Group） ・市場機会・将来傾向 |
The aseptic sampling market is registered a CAGR of nearly 10.24% during the forecast period. The major factors attributing to the growth of the aseptic sampling market are the rise in the demand for biopharmaceuticals which resulted in the increased adoption of single-use aseptic sampling products.
Movover, owing to the COVID 19 situation, there were many of the companies focused on the development of the effective vaccines, biologics and drugs to prevent/cure the disease. This is increased demand for aseptic testing. However, due to the slow down of development and manufacturing of other pharmaceuticals or biologics coupled with supply chain disruption, the market has witnessed difficulties in 2020.
On the other hand, with growing spending on healthcare and drug development by companies and governments all over the world, aseptic sampling is projected to grow notably over the period. According to the United States Food and Drug Administration, there were about 53 novel drugs approved in 2020 compared to 48 in 2019. Moreover, as per 10th march 2021, there were additional 12 novel drugs approved in United States. In additionas a result of the increase in government expenditure for healthcare, government regulations to ensure drug safety, R&D activities in the segment increase globally, fueling the aseptic sampling market.
Key Market Trends
Biotechnology and Pharmaceutical Manufacturers Expected to Have Notable growth
In the aseptic sampling market, biotechnology and pharmaceutical manufacturers are expected to have notable growth owing to the growing R&D spending, growing biological and pharmaceutical pipeline. According to the Pharmaceutical Research and Manufacturers of America 2020, in 2019, PhrMA company members have invested about USD 83 billion in worldwide R&D compared to compared to 79.6 billion in 2019. Similarly, according to the European Federation of Pharmaceutical Industries and Associations 2018, In 2017, there an estimated 35,200 million was spent on Pharmaceutical R&D in Europe. Furthermore, these are expected to increase further over the forecast period.
Also, advancements in product technologies and adoption by the pharma and biotech companies are expected to fuel the segment growth. For instance, in May 2020, Aventor Inc has launched OmniTop Sample Tubes Adjustable sampling system for designed specifically for the lower contamination risk and routine sampling in bioprocessing operations.
Also, with the COVID 19 situation, the manufacturing of essential drugs has been increased tremendously in the majority of the countries in Europe and Asia. The countries around the world are focusing on strengthening the increasing the manufacturing capacity locally and strengthening it requirements on quality of the pharma and biotech procuducts, which is likely to fuel the market growth for aseptic sampling over the period.
North America Projected to Have Significant Share Over the Forecast Period.
North America projected to have a notable share of the aseptic sampling market and expected to do the same in the forecast period. Also, the increase in government expenditure for the healthcare sector, early product launches, and stringent government regulations regarding the safety and quality of various drugs will drive the North American aseptic sampling market.
The United States expected to have a significant share owing to the presence of key market players and rising support of the government on production and quality of pharma and biotech products. According to the Organisation for Economic Co-operation and Development (OECD) statistics 2020, in 2018, United States biotechnology companies has spent around 14.9% of the business expenditure of biotechnology. Whereas, Canada has spent only 3.6%.
The Asia Pacific aseptic sampling market is anticipated to show the highest growth rate in throughout the forecast period, owing to large-scale investments made by the key players. Furthermore, the increasing research activities in developing countries, such as China and India will give rise to advanced technological equipment and sampling techniques which boost the market growth in the region.
Competitive Landscape
The aseptic sampling market is moderately competitive and consists of several major players. Some of the market players operating in the market include GEA Group, Gemu Group, Gore & Associates, Keofitt A/S, Lonza Group, Merck KGaA, Qualitru Sampling Systems, Saint Gobain, Sartorius Stedim Biotech and Thermo Fisher Scientific among others. Some prominent players are acquiring the products, entering into partnerships with other companies to consolidate their market positions across the globe and while others are distributing products. For instance, in June 2017, Aseptic Technologies and MedCision LLC the world leader in next-generation automated cell thawing for advanced therapies has collaborated to expand the integration of Aseptic’s AT-Closed Vials for sample storage with specially designed versions of MedCision’s ThawSTAR therapeutic cell thawing system.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Stringent Government Regulations for Ensuring Drug Safety
4.2.2 Increasing Demand for Biopharmaceuticals to Eliminate the Risk of Contamination
4.3 Market Restraints
4.3.1 Issues Related to Leachable and Extractables With the Plastic Materials in Sampling Procedure
4.3.2 Unknown Impurities Generated During the Biopharmaceutical Processes Due to Employment of High Temperatures
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type of Sampling
5.1.1 Manual Aseptic Sampling
5.1.1.1 Bags
5.1.1.2 Bottles
5.1.1.3 Others
5.1.2 Automated Aseptic Sampling
5.2 Application
5.2.1 Upstream Process
5.2.2 Downstream Process
5.3 End-User
5.3.1 Biotechnology and Pharmaceutical Manufacturers
5.3.2 Contract Research and Manufacturing Organizations
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Merck KGaA
6.1.2 Sartorius Stedim Biotech
6.1.3 Keofitt A/S
6.1.4 Saint Gobain
6.1.5 GEA Group
6.1.6 Qualitru Sampling Systems
6.1.7 Thermo Fisher Scientific
6.1.8 Gemu Group
6.1.9 Gore & Associates
6.1.10 Lonza Group
7 MARKET OPPORTUNITIES AND FUTURE TRENDS